Masimo Co. (NASDAQ:MASI) Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D reduced its holdings in shares of Masimo Co. (NASDAQ:MASI) by 38.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,542 shares of the medical equipment provider’s stock after selling 10,124 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Masimo were worth $2,083,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Riverview Trust Co acquired a new position in shares of Masimo during the 1st quarter worth about $25,000. GAMMA Investing LLC lifted its holdings in shares of Masimo by 75.0% in the 2nd quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 111 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Masimo by 851.6% in the 4th quarter. EverSource Wealth Advisors LLC now owns 295 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 264 shares during the last quarter. Parallel Advisors LLC lifted its holdings in shares of Masimo by 48.3% in the 4th quarter. Parallel Advisors LLC now owns 445 shares of the medical equipment provider’s stock valued at $52,000 after purchasing an additional 145 shares during the last quarter. Finally, Lazard Asset Management LLC lifted its holdings in shares of Masimo by 5,730.0% in the 1st quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider’s stock valued at $85,000 after purchasing an additional 573 shares during the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Up 8.7 %

MASI opened at $121.42 on Friday. The business has a 50 day moving average price of $115.01 and a two-hundred day moving average price of $125.04. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The company has a market cap of $6.46 billion, a PE ratio of 82.60 and a beta of 0.98. Masimo Co. has a 52 week low of $75.22 and a 52 week high of $153.93.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, beating the consensus estimate of $0.77 by $0.09. The firm had revenue of $496.30 million during the quarter, compared to the consensus estimate of $493.92 million. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The firm’s revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.62 EPS. As a group, research analysts anticipate that Masimo Co. will post 3.87 EPS for the current year.

Analyst Ratings Changes

MASI has been the subject of several research reports. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Friday. Piper Sandler boosted their target price on Masimo from $160.00 to $165.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Masimo presently has a consensus rating of “Moderate Buy” and a consensus price target of $144.67.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.